1000_F_881110133_ZEvLWErC3IKFehYaOP4W9DikmQbMT7la

The Security of Onshore Manufacturing
Noramco CEO Lee Karras discusses $25 million Halo investment with PharmTech
Diversifying the Supply of Raw Materials
Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider
Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit